Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Rating) was the target of a large drop in short interest in the month of December. As of December 30th, there was short interest totalling 1,400 shares, a drop of 26.3% from the December 15th total of 1,900 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is currently 0.2 days.

Algernon Pharmaceuticals Price Performance

Shares of OTCMKTS AGNPF opened at $1.64 on Thursday. Algernon Pharmaceuticals has a 1 year low of $1.52 and a 1 year high of $9.28. The stock's 50-day simple moving average is $1.90 and its 200-day simple moving average is $2.63.

Get Algernon Pharmaceuticals alerts:

Algernon Pharmaceuticals Company Profile

(Get Rating)

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada, Australia, and New Zealand.

Featured Stories

• Get a free copy of the StockNews.com research report on Algernon Pharmaceuticals (AGNPF)
• Procter & Gamble Earnings: A Gamble Worth Taking
• Stocks Slide, Economic Report Paints Gloomy Picture For Economy
• What does Nu Holdings Stock Have To Do With Warren Buffett?
• J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
• Is Intel Stock On The Verge Of Breaking Out?

Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.